Pure Global
NCT06327802

Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment

Pole Sante Grace de Dieu·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cystic Fibrosis
Drug/Device/Intervention
Questionnaire
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Pole Sante Grace de Dieu
Location
Caen, France
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jul 31, 2025
Enrollment
360 participants
Primary outcome

Zarit Burden Interview

Summary

The main objective of the study is to determine the impact of cystic fibrosis affecting a
 child on the parents' quality of life, their possible anxiety and depressive symptoms, their
 general fatigue and the feeling of burden in these caregivers.

ICD-10 classifications
Cystic fibrosisCystic fibrosis, unspecifiedCystic fibrosis with other manifestationsCystic fibrosis with pulmonary manifestationsCystic fibrosis with intestinal manifestations
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06327802
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06327802 through Pure Global AI's free database. This phase not specified trial is sponsored by Pole Sante Grace de Dieu and is currently Recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 360 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.